Assyro AI

FDA Orange Book · active-ingredient family

Ferumoxytol

Ferumoxytol is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:FERABRIGHT · NDA 219868

2

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

2

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
FERABRIGHTRLD×2AZURITYNDA 219868Oct 16, 2025
FERAHEMERLDAZURITYNDA 022180ABJun 30, 2009

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
FERUMOXYTOLSANDOZANDA 206604ABJan 15, 2021

Marketing exclusivity (2)

  • NPNew product exclusivity (3 years)

    Oct 16, 2028

    in 2 yr 4 mo

  • NPNew product exclusivity (3 years)

    Oct 16, 2028

    in 2 yr 4 mo

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ferumoxytol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.